Skip to main content

Master of Public Health

Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline.

AUTHORS

Hung AM , Roumie CL , Greevy RA , Grijalva CG , Liu X , Murff HJ , Ikizler TA , Griffin MR , . Clinical journal of the American Society of Nephrology : CJASN. 2016 11 8; ().
  • NIHMSID: 101271570

ABSTRACT

Diabetes is the leading cause of ESRD. Glucose control improves kidney outcomes. Most patients eventually require treatment intensification with second-line medications; however, the differential effects of those therapies on kidney function are unknown.

Diabetes is the leading cause of ESRD. Glucose control improves kidney outcomes. Most patients eventually require treatment intensification with second-line medications; however, the differential effects of those therapies on kidney function are unknown.

Tags: